Guerbet SA logo

GBT - Guerbet SA Share Price

€32.75 -0.5  -1.4%

Last Trade - 09/04/21

Mid Cap
Market Cap £357.5m
Enterprise Value £546.8m
Revenue £676.9m
Position in Universe 360th / 848
Unlock GBT Revenue
Relative Strength (%)
1m +1.15%
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -13.8%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2014 2015 2016 2017 2018 2019 2020E 2021E CAGR / Avg
409 488.7 775.8 807.1 789.6 816.9 716.7 741.3 +14.8%
+29.2 +52.8 -26.3 +58.9 -7.0 -13.6 -42.6 +22.7
Balance Sheet
FINANCIAL BRIEF: : For the six months ended 30 June 2020, Guerbet SArevenues decreased 9% to EUR363.7M. Net income applicableto common stockholders decreased 57% to EUR8.2M. Revenuesreflect MRI segment decrease of 20% to EUR107.3M, X-rayssegment decrease of 12% to EUR163.6M, Other Europeansegment decrease of 16% to EUR158.1M, Rest of the worldsegment decrease of 3% to EUR205.6M.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Latest News & Insights for GBT
Graphical History


GBT Revenue Unlock GBT Revenue

Net Income

GBT Net Income Unlock GBT Revenue

Normalised EPS

GBT Normalised EPS Unlock GBT Revenue

PE Ratio Range

GBT PE Ratio Range Unlock GBT Revenue

Dividend Yield Range

GBT Dividend Yield Range Unlock GBT Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
GBT EPS Forecasts Unlock GBT Revenue
Profile Summary

Guerbet SA is a France-based pharmaceutical group specialized in the manufacture and marketing of medical imaging contrast agents destined for diagnostic purposes. It produces medical imaging contrast products for x-ray imaging, magnetic resonance imaging (MRI), ultrasound imaging and for nuclear medicine. The contrast agents are used in the diagnosis of cardio-vascular, inflammatory and neuro-degenerative disorders. The Company’s portfolio of products comprises brands, such as Xenetix, Hexabrix, Optiray, Oxilan, Telebrix, Lipiodol, Dotarem, Endorem, Artirem, Lumirem, and Lipiodol, among others. Guerbet SA is also active in the fine chemicals industry through its Simafex subsidiary. The Company operates through its subsidiaries, including Simafex, Medex, SCI KALB, Guerbet LLC, Guerbet Asie Pacifique and Guerbet GmbH, among others.

Last Annual December 31st, 2019
Last Interim June 30th, 2020
Incorporated January 1, 1968
Public Since January 15, 1986
No. of Shareholders: n/a
No. of Employees: 2,820
Sector Healthcare
Industry Pharmaceuticals
Index CAC Mid & Small , CAC Small , CAC All-tradable , Enternext Pea-pme 150 ,
Exchange Euronext - Paris
Shares in Issue 12,578,668
Free Float (0.0%)
Eligible for
GBT Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for GBT
Upcoming Events for GBT
Friday 28th May, 2021 Estimate
Guerbet SA Annual Shareholders Meeting
Frequently Asked Questions for Guerbet SA
What is the Guerbet SA share price?

As of 09/04/21, shares in Guerbet SA are trading at €32.75, giving the company a market capitalisation of £357.5m. This share price information is delayed by 15 minutes.

How has the Guerbet SA share price performed this year?

Shares in Guerbet SA are currently trading at €32.75 and the price has moved by 8.8% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Guerbet SA price has moved by -15.28% over the past year.

What are the analyst and broker recommendations for Guerbet SA?

Of the analysts with advisory recommendations for Guerbet SA, there are there are currently 0 "buy" , 4 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Guerbet SA is Hold. You can view the full broker recommendation list by unlocking its StockReport.

When will Guerbet SA next release its financial results?

Guerbet SA is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-06-30
What is the Guerbet SA dividend yield?

The Guerbet SA dividend yield is 2.14% based on the trailing twelve month period.

Does Guerbet SA pay a dividend?

Last year, Guerbet SA paid a total dividend of 0.7, and it currently has a trailing dividend yield of 2.14%. Looking ahead, Guerbet SA has not announced an ex-dividend date yet.

When does Guerbet SA next pay dividends?

Guerbet SA has yet to annouce their ex-dividend date. The historic dividend yield on Guerbet SA shares is currently 2.14%.

How do I buy Guerbet SA shares?

To buy shares in Guerbet SA you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Guerbet SA?

Shares in Guerbet SA are currently trading at €32.75, giving the company a market capitalisation of £357.5m.

Where are Guerbet SA shares listed? Where are Guerbet SA shares listed?

Here are the trading details for Guerbet SA:

Country of listing: France
Exchange: PAR
Ticker Symbol: GBT
What kind of share is Guerbet SA?

Based on an overall assessment of its quality, value and momentum, Guerbet SA is currently classified as a Contrarian. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Guerbet SA share price forecast 2021?

Shares in Guerbet SA are currently priced at €32.75. At that level they are trading at 1.77% discount to the analyst consensus target price of 0.00.

Analysts covering Guerbet SA currently have a consensus Earnings Per Share (EPS) forecast of 1.73 for the next financial year.

How can I tell whether the Guerbet SA share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Guerbet SA. Over the past six months, the relative strength of its shares against the market has been -2.42%. At the current price of €32.75, shares in Guerbet SA are trading at 5.55% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Guerbet SA PE Ratio?

The Guerbet SA PE ratio based on its reported earnings over the past 12 months is 15.62. The shares are currently trading at €32.75.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of Guerbet SA?

Guerbet SA's management team is headed by:

Claire Corot - VBD
Marie-Claire Janailhac-Fritsch - CHM
Marion Barbier - DRC
Mark Fouquet - DRC
Claire Jouault-Massiot - DRC
Celine Lamort - DRC
Eric Guerbet - DRC
Francois Nicolas - EXB
Pierre Andre - DCE
Jean-Francois Blanc - EXB
David Hale - CEO
Jerome Estampes - CFO
Philippe Bourrinet - VPR
Petra Zalabak - VPR
Sarah Dayre - SVP
Who are the major shareholders of Guerbet SA?

Here are the top five shareholders of Guerbet SA based on the size of their shareholding:

Guerbet Family Individual Investor
Percentage owned: 54.65% (6.89m shares)
La Financière de l'Echiquier Investment Advisor
Percentage owned: 3.66% (461k shares)
Echiquier Entrepreneurs Mutual Fund
Percentage owned: 2.98% (376k shares)
Guerbet SA Employees Corporation
Percentage owned: 2.69% (339k shares)
Norges Bank Investment Management (NBIM) Sovereign Wealth Fund
Percentage owned: 2.22% (279k shares)
Similar to GBT
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.